{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:01:25Z","timestamp":1777597285975,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-02072-2","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:27:22Z","timestamp":1762252042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of cabozantinib on plasma adrenocorticotropic hormone and serum cortisol levels in patients with metastatic renal cell carcinoma: a retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yuji","family":"Hataya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuka","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiaki","family":"Murabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Hakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanta","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Iwakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinari","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"2072_CR1","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1210\/jc.2018-01836","volume":"104","author":"C Colombo","year":"2019","unstructured":"Colombo C, De Leo S, Di Stefano M, Vannucchi G, Persani L, Fugazzola L. Primary adrenal insufficiency during lenvatinib or vandetanib and improvement of fatigue after cortisone acetate therapy. J Clin Endocrinol Metab. 2019;104:779\u201384.","journal-title":"J Clin Endocrinol Metab"},{"key":"2072_CR2","first-page":"46","volume":"32","author":"S Monti","year":"2022","unstructured":"Monti S, Presciuttini F, Deiana MG, Motta C, Mori F, Renzelli V, et al. Cortisol deficiency in lenvatinib treatment of thyroid cancer: an underestimated common adverse event. Thyroid. 2022;32:46\u201353.","journal-title":"Thyroid"},{"key":"2072_CR3","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s40618-023-02025-3","volume":"46","author":"L Valerio","year":"2023","unstructured":"Valerio L, Giani C, Matrone A, Pontillo-Contillo B, Minaldi E, Agate L, et al. Adrenal insufficiency in thyroid cancer patients treated with tyrosine kinase inhibitors and detected by ACTH stimulation test. J Endocrinol Invest. 2023;46:1663\u201371.","journal-title":"J Endocrinol Invest"},{"key":"2072_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1053\/j.seminoncol.2023.11.003","volume":"50","author":"S Martella","year":"2023","unstructured":"Martella S, Lucas M, Porcu M, Perra L, Denaro N, Pretta A, et al. Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects. Semin Oncol. 2023;50:144\u201348.","journal-title":"Semin Oncol"},{"key":"2072_CR5","doi-asserted-by":"publisher","first-page":"102454","DOI":"10.1016\/j.autrev.2019.102454","volume":"19","author":"R Percik","year":"2020","unstructured":"Percik R, Shlomai G, Tirosh A, Tirosh A, Leibowitz-Amit R, Eshet Y, et al. Isolated autoimmune adrenocorticotropic hormone deficiency: from a rare disease to the dominant cause of adrenal insufficiency related to check point inhibitors. Autoimmun Rev. 2020;19:102454.","journal-title":"Autoimmun Rev"},{"key":"2072_CR6","doi-asserted-by":"publisher","first-page":"dgaa553","DOI":"10.1210\/clinem\/dgaa553","volume":"105","author":"Y Shi","year":"2020","unstructured":"Shi Y, Shen M, Zheng X, Chen Y, Zhao R, Gu Y, et al. Icpis-induced autoimmune polyendocrine syndrome type 2: a review of the literature and a protocol for optimal management. J Clin Endocrinol Metab. 2020;105:dgaa553.","journal-title":"J Clin Endocrinol Metab"},{"key":"2072_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1210\/js.2017-00170","volume":"1","author":"AC Paepegaey","year":"2017","unstructured":"Paepegaey AC, Lheure C, Ratour C, Lethielleux G, Clerc J, Bertherat J, et al. Polyendocrinopathy resulting from pembrolizumab in a patient with a malignant melanoma. J Endocr Soc. 2017;1:646\u201349.","journal-title":"J Endocr Soc"},{"key":"2072_CR8","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.3390\/curroncol29070370","volume":"29","author":"I Druce","year":"2022","unstructured":"Druce I, Tawagi K, Shaw JLV, Ibrahim A, Lochnan H, Ong M. Routine screening for central and primary adrenal insufficiency during immune-checkpoint inhibitor therapy: an endocrinology perspective for oncologists. Curr Oncol. 2022;29:4665\u201377.","journal-title":"Curr Oncol"},{"key":"2072_CR9","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:364\u201389.","journal-title":"J Clin Endocrinol Metab"},{"key":"2072_CR10","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.3390\/cancers14194610","volume":"14","author":"E Raschi","year":"2022","unstructured":"Raschi E, Fusaroli M, Giunchi V, Repaci A, Pelusi C, Mollica V, et al. Adrenal insufficiency with anticancer tyrosine kinase inhibitors targeting vascular endothelial growth factor receptor: analysis of the FDA adverse event reporting system. Cancers (Basel). 2022;14:4610.","journal-title":"Cancers (basel)"},{"key":"2072_CR11","doi-asserted-by":"publisher","first-page":"H560","DOI":"10.1152\/ajpheart.00133.2005","volume":"290","author":"T Kamba","year":"2006","unstructured":"Kamba T, Tam BYY, Hashizume H, Haskell A, Sennino B, Mancuso MR, et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol. 2006;290:H560\u201376.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2072_CR12","doi-asserted-by":"publisher","first-page":"12018","DOI":"10.1073\/pnas.1301331110","volume":"110","author":"Y Yang","year":"2013","unstructured":"Yang Y, Zhang Y, Cao Z, Ji H, Yang X, Iwamoto H, et al. Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues. Proc Natl Acad Sci USA. 2013;110:12018\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2072_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1634\/theoncologist.12-1-107","volume":"12","author":"EP Rock","year":"2007","unstructured":"Rock EP, Goodman V, Jiang JX, Mahjoob K, Verbois SL, Morse D, et al. Food and drug administration drug approval summary: sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma. Oncologist. 2007;12:107\u201313.","journal-title":"Oncologist"},{"key":"2072_CR14","doi-asserted-by":"publisher","first-page":"bvab022","DOI":"10.1210\/jendso\/bvab022","volume":"5","author":"BR Javorsky","year":"2021","unstructured":"Javorsky BR, Raff H, Carroll TB, Algeciras-Schimnich A, Singh RJ, Col\u00f3n-Franco JM, et al. New cutoffs for the biochemical diagnosis of adrenal insufficiency after ACTH stimulation using specific cortisol assays. J Endocr Soc. 2021;5:bvab022.","journal-title":"J Endocr Soc"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02072-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-02072-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02072-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T22:27:21Z","timestamp":1762295241000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-02072-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2072"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-02072-2","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"3 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the principles of the Declaration of Helsinki. This study was approved by the Ethics Committee of the Kobe City Medical Center General Hospital (Approval No. zn250110). The requirement for informed consent was waived by the Research Ethics Committee of Kobe City Medical Center General Hospital due to the retrospective nature of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}